MAIA Biotechnology, Inc.: director Chaouki Steven M received 32,774 shares

What happened

• Chaouki Steven M, a director, received an award of 32,774 shares (derivative stock options) on Sep 30, 2026. Price reported: $0; total value reported: $0.
• Transaction type reported as A (award/grant); the filing lists the instrument as a derivative.

Key details

• Transaction date and price: Sep 30, 2026 at $0.
• Shares reported in the transaction: 32,774 (derivative award).
• Shares owned after the transaction: not disclosed in the Form 4 filing.
• Footnote F1: The stock options, granted on Sep 30, 2026 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
• Filing timeliness: not indicated as late in the provided filing details.

Why it may matter

• This was an option award (an equity grant), not a market sale or purchase. The footnote states the options vest 100% on the grant date and are immediately exercisable.
• The filing does not show why the insider traded or why the company acted.